Europe Syringe Infusion Pump Market Size, Share & Trends Analysis Report By Disease Indication (Chemotherapy, Gastroenterology, Hematology), By End-use, By Country, And Segment Forecasts,
Published Date: May - 2025 | Publisher: MIR | No of Pages: 240 | Industry: healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2999 Download Sample Ask for Discount Request CustomizationEurope Syringe Infusion Pump Market Trends
The size of the Europe syringe infusion pumps market was estimated at USD 465.1 million in 2024 and is expected to grow at a CAGR of 7.9% during the period 2025-2030. Increased adoption in intensive care units, particularly for pediatric therapy, is mainly due to the accuracy provided by the product, versatility with different applications, and user-friendliness.
Syringe infusion pumps minimize human error and permit precise dosing, and hence patient outcomes are enhanced. Growing demand for quality care and patient safety, and the integration of technology-aided equipment in the healthcare industry, is anticipated to drive growth over the forecast period.
The rise in the incidence of chronic diseases in Europe has led to an increase in the use of technology-enabled devices and equipment in the healthcare industry. Healthcare professionals favor these devices to treat patients in pediatrics, neonatal intensive care, chronic diseases, and other complicated medical conditions. These conditions usually involve controlled drug delivery and accurate dosing, which are critical in determining patient outcomes. Syringe infusion pumps readily address such issues with essential features like accurate performance, small size, easy operations, real-time monitoring, and more.
Over the past few years, Europe has witnessed a sharp rise in incidence related to a variety of health conditions. For example, close to 500,000 premature births are seen in Europe every year, and premature birth ranks among the primary causes of mortality in children aged below 5 years in the region. The rising incidence rate of such conditions has raised the use of advanced devices and equipment like syringe infusion pumps.
Substantial increase in hospitalizations, particularly in intensive care units, from chronic illnesses like cancer, diabetes, cardiovascular disease, respiratory conditions, and traumatic injuries, is expected to propel this market's growth. As per the European Cancer Organization, 300,000 EU citizens are diagnosed with hematological malignancy, which includes leukemia and lymphoma. The rising prevalence of blood disorders in Europe, expansive growth in premature births, and increasing use of syringe infusion pumps for precise delivery of fluids and drugs in situations where oral therapy is not possible are expected to provide more growth prospects.
Report Coverage & Deliverables
PDF report & online dashboard will help you understand
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
Disease Indication Insights
The pediatrics/neonatology segment led the market with the largest revenue share of 26.2% in 2024. A growing number of premature births in the region and the use of syringe infusion pumps by healthcare professionals for controlled delivery of IV anesthetic drugs, fluids, dextrose, and other medications are primarily driving the growth of this segment. Infants' Sensitivity to drugs and risks associated with dosing and delivery necessitate using equipment such as syringe infusion pumps. The emergence of technologies such as Dose Error Reduction Software (DERS) facilitates the growing adoption. In addition, the presence of stringent European Union regulations, such as The Paediatric Regulation (EC), also leads to the use of efficient systems and medical devices that ensure the safety of patients.
The chemotherapy segment is anticipated to grow at the fastest CAGR of 8.8% over the forecast period. Syringe infusion pumps are primarily used for controlled delivery of chemotherapy drugs and administration of multiple medications related to palliative care simultaneously run during the chemotherapy. Minimizing side effects and early integration of palliative care with chemotherapy are vital in improving patient outcomes. Europe has experienced nearly a 60.0% increase in newly diagnosed cancer cases since 1995, and cancer is likely to become the leading cause of death in Europe by 2035. The rising prevalence of cancer and growing focus on the integration of palliative care during chemotherapy are expected to drive the growth of this segment.
End Use Insights
The hospitals segment had the maximum market revenue share in 2024. Hospitals provide a range of healthcare treatments related to critical care, palliative care, neonatal care, oncology, and others that involve the utilization of technology-based devices like syringe infusion pumps for ensuring error-free use and better patient outcomes. Increasing breadth of applications across chemotherapy, pain management, cardiovascular disorders, gastrointestinal disorders, pediatric care, and others is likely to drive adoption. The availability of qualified experts with the appropriate know-how to use such devices and an upward trend in the volume of admissions are likely to contribute to growth in this segment.
The homecare segment is likely to exhibit the highest CAGR of 8.7% during the forecast period. The growth in chronic diseases indicates the requirement for long-term care and proper medication. This increases interest in homecare syringe infusion pumps for safe therapy outside hospitals as healthcare moves towards ambulatory and home-based care. Easy-to-use devices that ensure ease of use and cost savings are increasingly used in the region. Advances in technology, including enhanced connectivity and remote monitoring functionality, are anticipated to drive increased adoption.
Country Insights
The German syringe infusion pumps market held the highest market revenue share of 24.06% in Europe in 2024. The strong manufacturing base present in the country, availability of several syringe infusion pump manufacturers in Germany, the rising emphasis of healthcare services providers on providing technology-enabled care, and rising adoption influenced by rising incidences of chronic diseases are driving the growth. Over the past few years, Germany has witnessed a high rate of new cases with breast cancer, prostate cancer, colon cancer, and lung cancer. Moreover, close to 8.5 million people in Germany are diagnosed with diabetes. An increase in the incidence rate of such illnesses is anticipated to drive higher use of syringe infusion pumps in Germany during the forecast period.
The France syringe infusion pumps market will grow at the highest CAGR during 2025-2030 in France. France has been adopting several strategies and screening programs to diagnose cancer early and treat it better in the country. For example, Stratégie Décennale de lutte contre les cancers 2021-2030, a cancer strategy for ten years was established to embark on primary and secondary prevention of cancer in the country. This has resulted in the increased use of palliative care interventions and initiatives to minimize mortality and improve patient outcomes.
Key Europe Syringe Infusion Pump Company Insights
Key players in the Europe syringe infusion pumps industry include B. Braun SE, Fresenius Kabi AG, Micrel Medical Devices SA, CODAN Companies, Arcomed and others. The major players focus on innovation, collaborations, and growth through acquisitions and mergers to address competition and increasing adoption.
-
B. Braun SE is a medical technology company that provides various healthcare products and services for diabetes care, extracorporeal blood treatment, neurosurgery, nutrition, ostomy surgery, and more. It offers an extensive range of infusion pumps and accessories, including the Perfusor range.
-
Fresenius Kabi AG is a healthcare company operating in therapeutic areas such as anesthesia, biosimilar, oncology, renal, and liver insufficient. It also manufactures infusion pumps for fluid management, critical illness, and blood volume substitutions.
Key Europe Syringe Infusion Pump Companies
- B. Braun SE
- Baxter
- BD
- Fresenius Kabi AG
- Micrel Medical Devices SA
- CODAN Companies
- Arcomed
- ICU Medical, Inc. (Smiths Medical)
- Terumo Corporation
- Moog Inc.
Recent Developments
-
In December 2023, Fresenius Kabi released that it had signed a multi-year contract with the Mayo Clinic, for the anticipated purchase of close to 10,000 units of Ivenix large-volume infusion pumps. This has improved its strategic moves to increase the uptake of its technology-based devices.
In February 2023, a medical technology company called Mindray rolled out BeneFusion i/u Series infusion systems. The systems, fueled by new-generation technologies, added to the portfolio of safe medication innovation technologies within the company.
Europe Syringe Infusion Pumps Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 498.9 million |
|
Revenue forecast in 2030 |
USD 729.5 million |
|
Growth rate |
CAGR of 7.9% from 2025 to 2035 |
|
Base year for estimation |
2024 |
|
Historical data |
2018 - 2023 |
|
Forecast period |
2025 - 2035 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2035 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends |
|
Segments covered |
Disease indication, end use, country |
|
Regional scope |
Europe |
|
Country scope |
Germany; UK; France; Italy; Spain; Denmark; Norway; Sweden |
|
Key companies profiled |
B. Braun SE; Baxter; BD; Fresenius Kabi AG; Micrel Medical Devices SA; CODAN Companies; Arcomed; ICU Medical, Inc. (Smiths Medical); Terumo Corporation; Moog Inc. |
|
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
Europe Syringe Infusion Pump Market Report Segmentation
Disease Indication Outlook (Revenue, USD Million, 2018 - 2035)
-
-
Chemotherapy
-
Diabetes
-
Gastroenterology
-
Analgesia/Pain Management
-
Pediatrics/Neonatology
-
Hematology
-
Others
-
-
End Use Outlook (Revenue, USD Million, 2018 - 2035)
-
Hospitals
-
Homecare
-
Others (ASC, Nursing Homes, Rehabilitation Centers)
-
-
Country Outlook (Revenue, USD Million, 2018 - 2035)
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Denmark
-
Norway
-
Sweden
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy